
Vaccines Advisory Committee to Meet on October 22
Hahn promises transparency in the review and approval of COVID-19 vaccines.
FDA announced the agency will hold a public meeting of the Vaccines and Related Biological Products Advisory Committee on Oct. 22, 2020 to discuss the development, authorization, and/or licensure of COVID-19 vaccines. The meeting is scheduled from 10 am–5 pm ET via webcast.
“The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee to address the general development of COVID-19 vaccines on October 22nd. The agency is also prepared to rapidly schedule additional meetings of this committee upon submission of any applications as appropriate,” said FDA Commissioner Stephen M. Hahn, in an Aug. 28, 2020
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.